Friday, October 28 2016


Use of Quinvaxem suspended after infant's death

Update: September, 15/2015 - 18:57
Illustrative photo. — VNA/VNS Photo

DAK NONG (VNS) — The Dak Nong Province's health department has halted the use of a batch of Quinvaxem vaccine, given to infants for free in the National Expanded Programme for Immunisation (EPI).

Ha Van Hung, deputy head of the department, said the use of batch 1453304 of the vaccine was halted yesterday, following the death of a three-month old infant earlier in the Central Highland province this month.

The department was collaborating with the EPI to ensure efficient quantities of a substitute Quinvaxem vaccine in the province, Hung said.

On the morning of September 3, three-month-old Nguyen Duc Hieu was given a five-in-one Quinvaxem vaccine shot at a medical station in Nam Xuan Ward in Krong No District.

He was in a stable condition 40 minutes after being vaccinated. Then, at 4pm the same day, the baby developed unusual symptoms and died on the way to the district's general hospital.

After the incident, the vaccine batch, manufactured by Berna Biotech Korea Corporation with February 27, 2017 as the expiry date, was sealed and sent for testing.

The Quinvaxem batch 1453304 had 4,000 shots, of which 585 had been used.

The cause of the baby's death would not be determined till the forensic tests and police investigation were completed, a representative of the provincial health department said.

Quinvaxem, a liquid vaccine, which has been pre-qualified by the World Health Organisation (WHO), immunises babies against diphtheria, tetanus, whooping cough and hepatitis B, besides Hib (Haemophilus influenza Type B).

In 2013, the use of Quinvaxem was suspended nationwide after a series of adverse reactions were reported. Its use was allowed to be resumed after tests showed its safety and effectiveness. — VNS

Send Us Your Comments:

See also: